Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.80
Bid: 18.00
Ask: 19.60
Change: 1.25 (7.12%)
Spread: 1.60 (8.889%)
Open: 17.55
High: 0.00
Low: 0.00
Prev. Close: 17.55
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value Estimate/ Progress on Realisations

25 Jan 2017 07:00

RNS Number : 0186V
LMS Capital PLC
25 January 2017
 

25 January 2017

 

LMS Capital plc

 

Net Asset Value Estimate and Progress on Realisations

 

 

LMS Capital plc (the "Company") is a listed Investment Company focused on investing directly, and through third party funds, in small to medium size private companies in the UK, Europe and the US. Gresham House Asset Management Ltd ("GHAM") was appointed to manage the investment portfolio in August 2016, alongside a change of mandate from realisation to focused direct private equity investment at the smaller end of the market.

 

Since assuming the investment mandate, significant progress has been made in transitioning to external management and towards achieving target annualised cost savings. GHAM has progressively engaged with the underlying portfolio companies, implementing new investment processes under the guidance of its newly established Investment Committee, with a focus on long term shareholder value creation. GHAM has appointed Tim Farazmand to the Investment Committee. Tim has over 30 years' experience in UK mid-market private equity most recently as Managing Director of Lloyds Development Capital and was also Chairman of the British Venture Capital Association.

 

Net Asset Value Estimate

 

The Company has commenced the year end valuation review process which is based on the latest performance updates from portfolio companies and third party fund manager valuations. Whilst valuations of the Company's US investments have benefitted from currency movements, performance in some of the Company's investments has deteriorated since June 2016, impacting their respective valuations.

 

As a consequence, the Board currently estimates that the year-end net asset value will be in the region of £67 million (69.5p per share). This estimate is subject to further evaluation and completion of the annual audit. The estimate takes into account the tender offer in September 2016 which returned £6 million to shareholders and incorporates one off costs associated with the transition from being self-managed to an externally managed company. Once complete, this transition is expected to deliver estimated annualised savings of approximately £1 million.

 

The valuation methodology and policy adopted is consistent with prior years and is in line with IPEV guidelines and takes account of active sales processes where relevant.

 

Progress on Realisations

 

The Company has concluded an agreement to a two stage sale of one of its US investments. The exit valuation is in line with the NAV as of 30 June 2016. The stage 1 payment of $4.5 million was received on 23 January 2017. The second and final stage will be settled either as a one off payment of $5 million in January 2018 or a loan note repayable with interest in instalments over 4 years.

 

The Company has also agreed the realisation of its holding in a US listed companies fund. The realisation is expected to complete in stages during the first half of 2017. The first stage, representing 35% of the holding, has been completed at a premium to 30 June 2016 NAV and proceeds of $1.3 million have been received. The balance is due to be paid in the second quarter of 2017 and will be determined by the NAV of the fund at the time.

 

Realisations since the circular sent to shareholders on 27 July 2016 have totalled £6.9 million. As set out in the circular, when net realisation proceeds reach £12 million, up to £6 million will be returned to shareholders in a tender offer.

 

The company expects to announce its audited results in mid-March.

 

 

Enquiries:

 

LMS Capital PLC

Martin Knight, Chairman

 

0207 935 3555

 

Gresham House Asset Management

Graham Bird, Investment Director

 

0203 837 6275

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley

 

0207 742 4000

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVZLFLDFFZBBE
Date   Source Headline
1st Jun 20187:00 amRNSExercise of Warrants
1st May 20185:35 pmRNSAuthorisation of Gresham House AM as AIFM
27th Apr 20183:50 pmRNSResults of 2018 Annual General Meeting
27th Apr 20187:00 amRNS1st Quarter 2018 update
26th Apr 20184:34 pmRNSHolding(s) in Company
5th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSAnnual Report and Notice of Annual General Meeting
26th Mar 201812:40 pmRNSReceipt of proceeds from Brockton Capital LLP
15th Mar 20187:00 amRNSAnnual Financial Report
8th Feb 201810:29 amRNSHolding(s) in Company
8th Feb 20187:00 amRNSSale of Investment
24th Jan 20187:00 amRNSNet Asset Value Estimate as at 31 December 2017
4th Jan 20189:01 amRNSKey Information Document Announcement
19th Dec 20173:14 pmRNSHolding(s) in Company
15th Dec 20174:40 pmRNSSecond Price Monitoring Extn
15th Dec 20174:35 pmRNSPrice Monitoring Extension
7th Dec 201712:22 pmRNSHolding(s) in Company
27th Oct 20173:57 pmRNSDirector/PDMR Shareholding
26th Oct 20177:00 amRNS3rd Quarter 2017 update
6th Sep 20175:19 pmRNSHolding(s) in Company
6th Sep 20175:16 pmRNSHolding(s) in Company
6th Sep 20175:13 pmRNSHolding(s) in Company
6th Sep 20175:09 pmRNSHolding(s) in Company
6th Sep 20177:00 amRNSDirector/PDMR Shareholding
25th Aug 201712:12 pmRNSHolding(s) in Company
25th Aug 201712:10 pmRNSHolding(s) in Company
23rd Aug 20173:55 pmRNSDirector/PDMR Shareholding
22nd Aug 20174:21 pmRNSDirector/PDMR Shareholding
22nd Aug 20174:17 pmRNSDirector/PDMR Shareholding
15th Aug 20173:55 pmRNSPurchase of Own Shares and Total Voting Rights
15th Aug 20179:15 amRNSResults of Tender Offer
11th Aug 20171:42 pmRNSResults of General Meeting
26th Jul 20177:01 amRNSTender Offer
26th Jul 20177:00 amRNSHalf Year Results for Six Months to 30 June 2017
20th Jul 201712:00 pmRNSHolding(s) in Company
18th Jul 201710:38 amRNSHolding(s) in Company
27th Jun 20177:00 amRNSIncrease in Tender Offer
15th Jun 201710:18 amRNSNotification of proceeds of fund distribution
6th Jun 20177:00 amRNSReview of Liquid Resources & Proposed Tender Offer
2nd Jun 20174:17 pmRNSHolding(s) in Company
25th May 20174:16 pmRNS2017 Annual General Meeting
22nd May 20177:00 amRNS1st Quarter 2017 Update
21st Apr 20177:00 amRNS2016 Annual Report and Notice of 2017 AGM
19th Apr 20173:39 pmRNSHolding(s) in Company
6th Apr 20176:29 pmRNSHolding(s) in Company
6th Apr 20177:00 amRNSSale of Majority Stake in 365IT to CORETX
14th Mar 20177:00 amRNSPreliminary Results
25th Jan 20177:00 amRNSNet Asset Value Estimate/ Progress on Realisations
18th Nov 201610:49 amPRNChange of Auditor
11th Nov 201610:55 amPRNPDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.